D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 70 Citations 18,262 224 World Ranking 1055 National Ranking 570
Medicine D-index 74 Citations 18,660 222 World Ranking 12492 National Ranking 6621

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • DNA

Dimiter S. Dimitrov mainly focuses on Virology, Antibody, Immunology, Monoclonal antibody and Epitope. In most of his Virology studies, his work intersects topics such as Glycoprotein. Dimiter S. Dimitrov focuses mostly in the field of Antibody, narrowing it down to matters related to Acquired immunodeficiency syndrome and, in some cases, Human disease, Immune correlates and Antibody response.

As a member of one scientific family, Dimiter S. Dimitrov mostly works in the field of Immunology, focusing on Internal medicine and, on occasion, Gastroenterology, Lymphopoiesis and CD28. His study in the field of Antibodies monoclonal is also linked to topics like Paradigm shift. He has researched Epitope in several fields, including Immunoglobulin G, Viral envelope, Avidity and Peptide library.

His most cited work include:

  • Structural definition of a conserved neutralization epitope on HIV-1 gp120. (710 citations)
  • Structure of a V3-Containing HIV-1 gp120 Core (665 citations)
  • Evaluation of gene expression measurements from commercial microarray platforms (656 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Antibody, Virology, Monoclonal antibody, Molecular biology and Epitope. His research in Antibody tackles topics such as Antigen which are related to areas like Cancer research and T cell. His Virology research incorporates themes from Gp41, Immunology and Glycoprotein.

His Monoclonal antibody research incorporates elements of Hendra Virus, Biochemistry, Phage display and Peptide library. The study incorporates disciplines such as Protein structure, Cell culture, Plasma protein binding and Cell in addition to Molecular biology. The concepts of his Epitope study are interwoven with issues in Neutralizing antibody and Germline.

He most often published in these fields:

  • Antibody (45.55%)
  • Virology (40.20%)
  • Monoclonal antibody (27.99%)

What were the highlights of his more recent work (between 2017-2021)?

  • Antibody (45.55%)
  • Cancer research (10.69%)
  • Virology (40.20%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Antibody, Cancer research, Virology, Monoclonal antibody and Antigen. His Antibody study combines topics from a wide range of disciplines, such as Biochemistry, Glycoprotein and Mutant. His Cancer research study combines topics in areas such as Cancer cell, Cancer, Pediatric cancer, Immunotherapy and Neuroblastoma.

His work in the fields of Virus, Henipavirus and Hendra Virus overlaps with other areas such as Severe acute respiratory syndrome coronavirus 2. His Monoclonal antibody research is multidisciplinary, incorporating perspectives in Panning and Fusion protein. His research investigates the connection with Antigen and areas like Chimeric antigen receptor which intersect with concerns in CD22, Leukemia, CD33, Myeloid leukemia and Molecular biology.

Between 2017 and 2021, his most popular works were:

  • CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. (503 citations)
  • CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors (120 citations)
  • Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence (56 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

Dimiter S. Dimitrov spends much of his time researching Antibody, Antigen, Virology, Monoclonal antibody and Neutralization. His work investigates the relationship between Antibody and topics such as Glycoprotein that intersect with problems in Potency. The various areas that Dimiter S. Dimitrov examines in his Antigen study include Immunohistochemistry, Molecular biology, Myeloid leukemia and Chimeric antigen receptor, Immunotherapy.

His Virology research focuses on In vitro and how it connects with Panning. His research in Monoclonal antibody intersects with topics in Epitope, Virus, Germline and Dengue fever. His Neutralization research integrates issues from Host cell membrane, Hendra Virus, Henipavirus Infections, Henipavirus and Peptide library.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Structural definition of a conserved neutralization epitope on HIV-1 gp120.

Tongqing Zhou;Ling Xu;Barna Dey;Ann J. Hessell.
Nature (2007)

915 Citations

Structure of a V3-Containing HIV-1 gp120 Core

Chih-chin Huang;Min Tang;Mei-Yun Zhang;Shahzad Majeed.
Science (2005)

908 Citations

Evaluation of gene expression measurements from commercial microarray platforms

Paul K. Tan;Thomas J. Downey;Edward L. Spitznagel;Pin Xu.
Nucleic Acids Research (2003)

874 Citations

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun.
Proceedings of the National Academy of Sciences of the United States of America (1999)

837 Citations

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.

Terry J Fry;Nirali N Shah;Rimas J Orentas;Maryalice Stetler-Stevenson.
Nature Medicine (2018)

611 Citations

Quantitation of human immunodeficiency virus type 1 infection kinetics.

D. S. Dimitrov;R. L. Willey;H. Sato;Lung-Ji Chang.
Journal of Virology (1993)

571 Citations

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

Leonid Cherkassky;Aurore Morello;Jonathan Villena-Vargas;Yang Feng.
Journal of Clinical Investigation (2016)

474 Citations

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

Masashi Shingai;Yoshiaki Nishimura;Florian Klein;Hugo Mouquet.
Nature (2013)

463 Citations

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

Waleed Haso;Daniel W. Lee;Nirali N. Shah;Maryalice Stetler-Stevenson.
Blood (2013)

462 Citations

Virus entry: molecular mechanisms and biomedical applications

Dimiter S. Dimitrov.
Nature Reviews Microbiology (2004)

454 Citations

Best Scientists Citing Dimiter S. Dimitrov

Dennis R. Burton

Dennis R. Burton

Scripps Research Institute

Publications: 179

Shibo Jiang

Shibo Jiang

Fudan University

Publications: 165

John R. Mascola

John R. Mascola

National Institutes of Health

Publications: 137

David C. Montefiori

David C. Montefiori

Duke University

Publications: 131

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 122

Peter D. Kwong

Peter D. Kwong

National Institutes of Health

Publications: 121

Michel C. Nussenzweig

Michel C. Nussenzweig

Rockefeller University

Publications: 121

Ian A. Wilson

Ian A. Wilson

Scripps Research Institute

Publications: 105

Christopher C. Broder

Christopher C. Broder

Uniformed Services University of the Health Sciences

Publications: 101

Lin-Fa Wang

Lin-Fa Wang

Duke NUS Graduate Medical School

Publications: 95

Rogier W. Sanders

Rogier W. Sanders

University of Amsterdam

Publications: 93

Susan Zolla-Pazner

Susan Zolla-Pazner

Icahn School of Medicine at Mount Sinai

Publications: 86

Michael S. Seaman

Michael S. Seaman

Beth Israel Deaconess Medical Center

Publications: 83

Joseph Sodroski

Joseph Sodroski

Harvard University

Publications: 83

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 81

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.